Last C$3.04 CAD
Change Today +0.29 / 10.55%
Volume 54.2K
I On Other Exchanges
Symbol
Exchange
Toronto
NASDAQ CM
Frankfurt
As of 3:59 PM 09/2/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Shameze Rampertab B.Sc. MBA, CA, CPA

Chief Financial Officer and Vice President of Finance, IntelliPharmaCeutics International Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 2 different industries.

--$337,480
As of Fiscal Year 2013

Background*

Mr. Shameze Rampertab, B.Sc. MBA, CA has been the Chief Financial Officer and Vice President of Finance of IntelliPharmaCeutics International Inc., since November 29, 2010. Mr. Rampertab is a seasoned business finance leader in the healthcare sector with depth of experience in capital markets, finance, strategic planning and analysis. He spent 14 years in capital markets serving the life sciences sector. He served as a Director of Finance, Secretary and Treasurer of ...

Read Full Background

Corporate Headquarters*

30 Worcester Road
Toronto, Ontario M9W 5X2

Canada

Phone: 416-798-3001
Fax: 416-798-3007

Board Members Memberships*

2011-2012
Former Director

Education*

BS 1989
University of Toronto
MBA 1991
McMaster University

Other Affiliations*

Annual Compensation*

Salary$244,117
Total Annual Compensation$244,117

Stock Options*

All Other Compensation$11,718
Total Value of OptionsC$178,000
Total Number of Options125,000

Total Compensation*

Total Annual Cash Compensation$255,835
Total Short Term Compensation$244,117
Other Long Term Compensation$11,718
Total Calculated Compensation$337,480
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
I:CN C$3.04 CAD +0.29

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
James E. Brown D.V.M.Co-Founder, Chief Executive Officer, President and Director
DURECT Corporation
$450.7K
Pascal Soriot Chief Executive Officer, Executive Director and Member of Disclosure Committee
AstraZeneca PLC
3.0M GBP
Samir Uttamlal Mehta M.B.A.Executive Vice Chairman, Managing Director, Member of Securities Transfer & Stakeholders Relationship Committee and Member of Committee of Directors
Torrent Pharmaceuticals Ltd.
313.0K
Nilesh D. Gupta Managing Director and Executive Director
Lupin Limited
52.4M
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact INTELLIPHARMACEUTICS INTERNA, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.